Login

Christopher J. Schaber, CEO, Soligenix Inc 00:00:00

Share On Facebook Share On Twitter

Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights from a Veteran Real Estate Executive |Paul M. Williams, CEO , Derwent London PLC.
00:10:00
How Much Capital Do You Need to Start a Hedge Fund? Insights from Wells Fargo’s Patrick McCurdy | Market Makers
00:10:00
Roku founder and CEO Anthony Wood discussed the Roku Channel and the company's origins in a Fortt Knox interview
00:10:00
Understanding IRB's Role in NIH Data Management Policy: A Webinar Overview | Mark Hussey - CEO of Huron Consulting Group
00:10:00
Insights from Board Interview: Clarity's Founders, Healthcare, and Background |Dr Alan Taylor , Executive Chairma, Clarity Pharmaceuticals Ltd.
00:10:00
Yuri Milner Discusses Scientific and Technological Breakthroughs | Yuri Milner, Founder, DST Global.
00:00:00
4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma
00:10:00
Maloney Securities: A Broker-Driven Firm Focused on Client-Centric Success
00:10:00
18th Annual Capital Link International Shipping Forum | Product Tanker Sector Panel
00:10:00
Maria Shares Her Passion for Portland and Vision for Community Involvement | Maria Pope, CEO , Portland General Electric PLC.
00:10:00
Introducing Bast Gate's New Wireless Sensors: Simplified Setup and Customizable Solutions
00:10:00
Navigating the Intersection of AI and Biology: A Vision for Drug Discovery| Sean McClain, CEO, Absci Corp.

© 2026 Nehu